Prochlorperazine Maleate

马来酸丙氯拉嗪

Report date: 2026/03/30 17:02:26

Base Information

Drug NameProchlorperazine Maleate
Drug Alias Name丙氯拉嗪马来酸盐甲哌氯丙嗪马来酸盐马来酸甲哌氯丙嗪Staccato-prochlorperazineBuccastem +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaPsychotic DisordersAnxiety Disorders +[7] 
Global Approved IndicationsSchizophreniaAnxiety Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/10/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado Denver
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsAltitude Sickness
Inactive IndicationsSchizophreniaPsychotic DisordersAnxiety Disorders +[6] 

Other Information

ATC CodeN05AB04
Related LinksWikipediaDrugBankKEGG